Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Vanessa](/img/uploaded/aab593d7615a80d42da1c23d7d2bc16b.jpeg)
![Foto de Hospital Universitario La Fe](/img/noimage_org.png)
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (9)
2019
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
2018
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2017
2016
-
Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect
Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 8, pp. 1549-1560
2013
-
Association of the thrombomodulin gene c.1418c7gt;t polymorphism with thrombomodulin levels and with venous thrombosis risk
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 6, pp. 1435-1440
2012
-
miR-133a regulates Vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the Vitamin K cycle
Molecular Medicine, Vol. 18, Núm. 11, pp. 1466-1472
2010
-
Pharmacogenetics of acenocoumarol in patients with extreme dose requirements
Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 5, pp. 1012-1017
2009
-
Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis
Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486
2008
-
Endothelial protein C receptor polymorphisms and risk of myocardial infarction
Haematologica, Vol. 93, Núm. 9, pp. 1358-1363